Sassicaia Capital Advisers LLC Re Shape Lifesciences Inc. Transaction History

Sassicaia Capital Advisers LLC

  • $34.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.64 - $3.13 $16,400 - $31,300
-10,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.67 - $5.09 $26,700 - $50,900
10,000 New
10,000 $29,000

About ReShape Lifesciences Inc.

RSLS Quotes by TradingView
  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $103M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Sassicaia Capital Advisers LLC Portfolio

Follow Sassicaia Capital Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sassicaia Capital Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sassicaia Capital Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email